文献速递心律失常

心房颤动:JACC委员会观点

Atrial Fibrillation: JACC Council Perspectives.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

本文为JACC委员会关于心房颤动的当代综述,涵盖患病率、病理生理、风险预测、预防、治疗选择及优化结局的新见解。综述指出卒中与出血风险模型已建立并验证,房颤消融已成为主要治疗策略,肺静脉隔离是消融基石,非肺静脉部位消融日益被认可用于非阵发性房颤。

要点

  • 卒中预防决策工具不断演进,已有更好选择。
  • 房颤消融已成为主要治疗策略,肺静脉隔离是基石。
  • 非肺静脉部位消融对非阵发性房颤日益重要。

核心结论

  • 房颤治疗以率控制、节律控制和卒中预防为基石,房颤消融已成为主要治疗策略,肺静脉隔离是消融基石,非肺静脉部位消融对非阵发性房颤日益重要。

研究设计与样本

  • 本文为JACC委员会视角的当代综述,检索范围未在摘要中报告。

主要发现

  • 房颤是患病率日益增加的心律失常,其病理生理和进展已被充分研究。
  • 卒中与出血风险模型已建立并验证。
  • 卒中预防决策工具不断演进,已有更好选择。
  • 多种诊断工具可提供房颤负荷和血栓栓塞风险信息。
  • 抗心律失常药物有用,但房颤消融已成为主要治疗策略。

临床怎么用

  • 临床应综合运用率控制、节律控制和卒中预防管理房颤。
  • 房颤消融以肺静脉隔离为基石,非阵发性房颤可考虑非肺静脉部位消融。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atrial fibrillation (AF) is an increasingly prevalent arrhythmia; its pathophysiology and progression are well studied. Stroke and bleeding risk models have been created and validated. Decision tools for stroke prophylaxis are evolving, with better options at hand. Utilization of various diagnostic tools offer insight into AF burden and thromboembolic risk. Rate control, rhythm control, and stroke prophylaxis are the cornerstones of AF therapy. Although antiarrhythmic drugs are useful, AF ablation has become a primary therapeutic strategy. Pulmonary vein isolation is the cornerstone of AF ablation, and methods to improve ablation safety and efficacy continue to progress. Ablation of nonpulmonary vein sites is increasingly being recognized as an important strategy for treating nonparoxysmal AF. Several new ablation techniques and technologies and stroke prophylaxis are being explored. This is a contemporary review on the prevalence, pathophysiology, risk prediction, prophylaxis, treatment options, new insights for optimizing treatment outcomes, and emerging concepts of AF.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Chung MK, Refaat M, Shen WK, et al. Atrial Fibrillation: JACC Council Perspectives. J Am Coll Cardiol. 2020. PMID: 32273035. doi:10.1016/j.jacc.2020.02.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。